A reduction in TNFR2 signaling has been linked to impaired Treg function, contributing to an increased risk of autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) [34]. This evidence concerns the gene TNFRSF1B and systemic lupus erythematosus.